TNXP
NASD Tonix Pharmaceuticals Holding Corp.$9.73 ↓ -0.17 (-1.72%) Trading Down from the previous close of $9.90
- YTD change
- -37.71%
- vs 20-day SMA
- -17.72%
- vs 200-day SMA
- -28.96%
Price ranges
Price & Performance
-2.13 (-17.71%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $94,000.00
- TNXP is down 38% since the beginning of the year
- TNXP is down 61% over the past 12 months
- TNXP is down 28% over the past 1 month
- 18% of all TNXP investors are betting against TNXP
TNXP reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -60.0%.
- Previous minute
- +$0.00
- Last hour
- +$0.01
- Last 5 days
- -9.24%
- vs 8-day SMA
- -6.55%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
